南美洲和中美洲急性胰腺炎市场预测至 2030 年 - 区域分析 - 按产品(药物、诊断等)、原因(胆结石、酗酒、遗传性疾病、感染等)和最终用户(医院、诊断实验室、门诊)外科中心等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 93    |    Report Code: BMIRE00029244    |    Category: Life Sciences

South & Central America Acute Pancreatitis Market

南部和南部2022年中美洲急性胰腺炎市场价值为2.0904亿美元,预计到2030年将达到3.3367亿美元;预计 2022 年至 2030 年复合年增长率为 6.0%。

关于急性胰腺炎的研发活动和宣传项目数量激增,推动了南方和亚洲的发展。中美洲急性胰腺炎市场

全球范围内正在开展广泛的研究,以调查急性胰腺炎的病因、进展和治疗。国家胰腺基金会 (NPF) 提供多项研究资助,每个项目价值约 50,000 美元。迄今为止,NPF 已为 133 个突破性研究项目提供了超过 500 万美元的资金。授予为期一年的赠款,用于诊断和/或治疗胰腺炎、胰腺癌或小儿胰腺炎。

此外,国际上正在开展多项工作来定义急性胰腺炎的流行病学和病理生理学。美国国立卫生研究院 (NIH) 的国家糖尿病、消化和肾脏疾病研究所 (NIDDK) 于 2020 年组建了一个由 10 个临床中心和 1 个数据协调中心组成的协作网络,以解决有关急性胰腺炎的多个知识缺口。该联盟被称为急性胰腺炎联盟 (T1DAPC) 后的 1 型糖尿病。因此,针对急性胰腺炎开发有效疗法(通过直接和间接手段)的研发活动和宣传计划预计将为南方和美国的公司带来丰硕成果。中美洲急性胰腺炎市场。

南美洲和南美洲中美洲急性胰腺炎市场概况

南美洲和南美洲中美洲急性胰腺炎市场分为巴西、阿根廷和南美其他地区。中美洲。该地区老年人口的增加和急性胰腺炎病例的增加正在推动南部和非洲地区的增长。中美洲该地区的急性胰腺炎市场。急性胰腺炎是一种危及生命的疾病,尤其是由于合并症和身体系统受损而导致的老年人群。据巴西卫生部称,到 2030 年,巴西老年人口预计将在全球排名第五。世界卫生组织预计,到2050年,我国老年人口将增加300%以上,总人口将增长30%。据泛美卫生组织(PAHO)统计,2022年,巴西60岁以上人口将超过3000万,占总人口的30%。预计到2050年,60岁以上的人口将达到约5000万,占巴西总人口的24%。除了衰老之外,饮酒也会导致急性胰腺炎。根据《自然》杂志发表的一篇文章,巴西饮酒者总数的85.2%是重度饮酒者。因此,巴西酒精消费的增加也推动了南部和南部地区的增长。中美洲急性胰腺炎市场。

南美洲和南美洲中美洲急性胰腺炎市场收入和预测到 2030 年(百万美元)

南美洲和南美洲中美洲急性胰腺炎市场细分

 

南部和南部地区中美洲急性胰腺炎市场按产品、原因、最终用户

和国家/地区进行细分。中美洲急性胰腺炎市场分为药物、诊断等。诊断细分市场在 2022 年占据最大的市场份额。

根据原因,South &中美洲急性胰腺炎市场分为胆结石、酗酒、遗传性疾病、感染等。胆结石细分市场在 2022 年占据最大的市场份额。

根据最终用户,南部和南部地区中美洲急性胰腺炎市场分为医院、诊断实验室、门诊手术中心等。到 2022 年,医院细分市场占据最大的市场份额。中美洲急性胰腺炎市场分为巴西、阿根廷和南美其他地区。中美洲。南部和南部的其他地区中美洲主导了南美洲和南美洲。 2022 年中美洲急性胰腺炎市场份额。

雅培实验室 (Abbott Laboratories)、百特国际公司 (Baxter International Inc)、波士顿科学公司 (Boston Scientific Corp)、Fresenius Kabi AG、GE HealthCare Technologies Inc、Koninklijke Philips NV、美敦力公司 (Medtronic Plc) 和三星医疗保健 (Samsung Healthcare) 等公司在南部和南部地区运营的领先公司中美洲急性胰腺炎市场。



South & Central America Acute Pancreatitis Strategic Insights

Strategic insights for South & Central America Acute Pancreatitis involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-acute-pancreatitis-market-strategic-framework.webp
Get more information on this report

South & Central America Acute Pancreatitis Report Scope

Report Attribute Details
Market size in 2022 US$ 209.04 Million
Market Size by 2030 US$ 333.67 Million
Global CAGR (2022 - 2030) 6.0%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 供品
  • 药物
  • 诊断
By 原因
  • 胆结石
  • 酒精中毒
  • 遗传性疾病
  • 感染
By 最终用户
  • 医院
  • 诊断实验室
  • 门诊手术中心
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Abbott Laboratories
  • Baxter International Inc
  • Boston Scientific Corp
  • Fresenius Kabi AG
  • GE HealthCare Technologies Inc
  • Koninklijke Philips NV
  • Medtronic Plc
  • Samsung Healthcare
  • Get more information on this report

    South & Central America Acute Pancreatitis Regional Insights

    The regional scope of South & Central America Acute Pancreatitis refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-acute-pancreatitis-market-geography.webp
    Get more information on this report

    The List of Companies - South & Central America Acute Pancreatitis Market

    1. Abbott Laboratories
    2. Baxter International Inc
    3. Boston Scientific Corp
    4. Fresenius Kabi AG
    5. GE HealthCare Technologies Inc
    6. Koninklijke Philips NV
    7. Medtronic Plc
    8. Samsung Healthcare
    Frequently Asked Questions
    How big is the South & Central America Acute Pancreatitis Market?

    The South & Central America Acute Pancreatitis Market is valued at US$ 209.04 Million in 2022, it is projected to reach US$ 333.67 Million by 2030.

    What is the CAGR for South & Central America Acute Pancreatitis Market by (2022 - 2030)?

    As per our report South & Central America Acute Pancreatitis Market, the market size is valued at US$ 209.04 Million in 2022, projecting it to reach US$ 333.67 Million by 2030. This translates to a CAGR of approximately 6.0% during the forecast period.

    What segments are covered in this report?

    The South & Central America Acute Pancreatitis Market report typically cover these key segments-

  • 供品 (药物, 诊断)
  • 原因 (胆结石, 酒精中毒, 遗传性疾病, 感染)
  • 最终用户 (医院, 诊断实验室, 门诊手术中心)
  • What is the historic period, base year, and forecast period taken for South & Central America Acute Pancreatitis Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Acute Pancreatitis Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in South & Central America Acute Pancreatitis Market?

    The South & Central America Acute Pancreatitis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott Laboratories
  • Baxter International Inc
  • Boston Scientific Corp
  • Fresenius Kabi AG
  • GE HealthCare Technologies Inc
  • Koninklijke Philips NV
  • Medtronic Plc
  • Samsung Healthcare
  • Who should buy this report?

    The South & Central America Acute Pancreatitis Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South & Central America Acute Pancreatitis Market value chain can benefit from the information contained in a comprehensive market report.